Us Bancorp \De\ Novartis Ag Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Novartis Ag stock. As of the latest transaction made, Us Bancorp \De\ holds 242,627 shares of NVS stock, worth $24 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

242,627

Previous 216,477 12.08%

Holding current value

$24 Million

Previous $23 Million 21.09%

% of portfolio

0.04%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$106.13 - $120.89 $2.78 Million - $3.16 Million	26,150 Added 12.08%	242,627 $27.9 Million
Q2 2024 Aug 06, 2024	SELL	$92.57 - $107.37 $4.41 Million - $5.11 Million	-47,599 Reduced 18.02%	216,477 $23 Million
Q1 2024 May 07, 2024	SELL	$95.27 - $108.47 $235,031 - $267,595	-2,467 Reduced 0.93%	264,076 $25.5 Million
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $2.9 Million - $3.19 Million	31,452 Added 13.38%	266,543 $26.9 Million
Q3 2023 Nov 03, 2023	BUY	$94.73 - $105.13 $2.55 Million - $2.83 Million	26,946 Added 12.95%	235,091 $23.9 Million
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $326,318 - $370,017	3,527 Added 1.72%	208,145 $21 Million
Q1 2023 May 09, 2023	SELL	$80.03 - $92.81 $2.18 Million - $2.53 Million	-27,261 Reduced 11.76%	204,618 $18.8 Million
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $3.06 Million - $3.75 Million	40,537 Added 21.19%	231,879 $21 Million
Q3 2022 Oct 27, 2022	SELL	$74.61 - $87.26 $5 Million - $5.84 Million	-66,954 Reduced 25.92%	191,342 $14.5 Million
Q2 2022 Aug 01, 2022	BUY	$80.52 - $93.75 $1.73 Million - $2.01 Million	21,434 Added 9.05%	258,296 $21.8 Million
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $841,956 - $952,416	-10,510 Reduced 4.25%	236,862 $20.8 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $4.54 Million - $5.02 Million	-56,933 Reduced 18.71%	247,372 $21.6 Million
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $1.58 Million - $1.84 Million	-19,316 Reduced 5.97%	304,305 $24.9 Million
Q2 2021 Aug 05, 2021	BUY	$85.24 - $94.15 $1.66 Million - $1.83 Million	19,444 Added 6.39%	323,621 $29.5 Million
Q1 2021 Apr 28, 2021	BUY	$83.5 - $98.47 $718,601 - $847,432	8,606 Added 2.91%	304,177 $26 Million
Q4 2020 Feb 04, 2021	BUY	$78.07 - $94.43 $588,335 - $711,624	7,536 Added 2.62%	295,571 $27.9 Million
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $2.26 Million - $2.5 Million	-27,503 Reduced 8.72%	288,035 $25 Million
Q2 2020 Aug 07, 2020	SELL	$80.93 - $91.1 $445,519 - $501,505	-5,505 Reduced 1.71%	315,538 $27.6 Million
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $5.53 Million - $7.74 Million	78,210 Added 32.21%	321,043 $26.5 Million
Q4 2019 Feb 04, 2020	BUY	$84.35 - $95.37 $414,158 - $468,266	4,910 Added 2.06%	242,833 $23 Million
Q3 2019 Nov 08, 2019	BUY	$85.54 - $94.26 $3.58 Million - $3.95 Million	41,876 Added 21.36%	237,923 $20.7 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $2.33 Million - $2.86 Million	-30,850 Reduced 13.6%	196,047 $17.9 Million
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $5.05 Million - $5.77 Million	-67,031 Reduced 22.81%	226,897 $21.8 Million
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $3.35 Million - $3.73 Million	45,434 Added 18.28%	293,928 $25.2 Million
Q3 2018 Nov 01, 2018	BUY	$66.94 - $77.43 $1.93 Million - $2.23 Million	28,850 Added 13.13%	248,494 $21.4 Million
Q2 2018 Aug 08, 2018	BUY	$64.91 - $73.36 $779,504 - $880,980	12,009 Added 5.78%	219,644 $16.6 Million
Q1 2018 May 08, 2018	SELL	$70.39 - $84.15 $2.28 Million - $2.72 Million	-32,376 Reduced 13.49%	207,635 $16.8 Million
Q4 2017 Feb 02, 2018	BUY	$72.33 - $77.64 $1.5 Million - $1.61 Million	20,778 Added 9.48%	240,011 $20.2 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $16.3 Million - $16.9 Million	219,233	219,233 $18.8 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account